Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 5th edition, 486 pages

Free download


  Free Subscription


1 Acad Emerg Med
1 AJR Am J Roentgenol
1 Am J Respir Crit Care Med
2 Ann Intern Med
21 BMJ
3 Br J Anaesth
1 Clin Chem
7 Clin Infect Dis
3 Infect Control Hosp Epidemiol
7 Int J Infect Dis
1 Intensive Care Med
8 J Infect
9 J Med Virol
1 J Thorac Oncol
4 J Travel Med
4 J Virol
10 Lancet
2 Lancet Diabetes Endocrinol
2 Lancet Gastroenterol Hepatol
5 Lancet Infect Dis
1 Lancet Neurol
3 Lancet Respir Med
1 Life Sci
7 MMWR Morb Mortal Wkly Rep
5 N Engl J Med
6 Nature
1 Science
3 Travel Med Infect Dis
1 Zhonghua Jie He He Hu Xi Za Zhi

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acad Emerg Med

  1. PARWANI V, Goldenberg M, Venkatesh A
    Emergency Department Psychiatric Observation Units: Good Care and Good Money?
    Acad Emerg Med. 2020 Nov 2. doi: 10.1111/acem.14167.
    PubMed         Abstract available

    AJR Am J Roentgenol

  2. DEMIRJIAN NL, Fields BKK, Gholamrezanezhad A
    Role of Chest CT in Resource-Driven Healthcare Systems.
    AJR Am J Roentgenol. 2020 Jul 9:W1. doi: 10.2214/AJR.20.23498.

    Am J Respir Crit Care Med

  3. HALPIN DMG, Criner GJ, Papi A, Singh D, et al
    Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: The 2020 GOLD Science Committee Report on COVID-19 & COPD.
    Am J Respir Crit Care Med. 2020 Nov 4. doi: 10.1164/rccm.202009-3533.
    PubMed         Abstract available

    Ann Intern Med

  4. CENTOR RM, Andrews R
    Annals On Call - Remdesivir as Treatment for COVID-19.
    Ann Intern Med. 2020 Nov 5. doi: 10.7326/A19-0043.

  5. LYNCH HF, Bateman-House A, Joffe S
    Emergency Approvals for COVID-19: Evolving Impact on Obligations to Patients in Clinical Care and Research.
    Ann Intern Med. 2020 Nov 3. doi: 10.7326/M20-6703.


    Covid-19: "There is no alternative," says Johnson, announcing new restrictions for England.
    BMJ. 2020;371:m4247.

    Covid-19: Experts question evidence behind prime minister's promise of rapid tests.
    BMJ. 2020;371:m4254.

    Covid-19: US cases soar as Fauci warns of tough times ahead.
    BMJ. 2020;371:m4246.

  9. WISE J
    Covid-19: T cell response lasts for at least six months after infection, study shows.
    BMJ. 2020;371:m4257.

  10. BAVLI I, Sutton B, Galea S
    Harms of public health interventions against covid-19 must not be ignored.
    BMJ. 2020;371:m4074.

  11. MICHIE S, West R, Harvey N
    The concept of "fatigue" in tackling covid-19.
    BMJ. 2020;371:m4171.

    Covid-19: a fork in the road ahead for general practice or a knife severing the road behind?
    BMJ. 2020;371:m4231.

  13. MAHASE E
    Covid-19: UK government must "get its act together" as modelling suggests 85 000 deaths in second wave, experts say.
    BMJ. 2020;371:m4242.

  14. KNIGHT V
    US election: How covid-19 pushed doctors into the political arena like never before.
    BMJ. 2020;371:m4118.

    Resourcing primary care to tackle covid-19: cooperation, not competition.
    BMJ. 2020;371:m4227.

  16. RUGER JP
    Social justice as a foundation for democracy and health.
    BMJ. 2020;371:m4049.

  17. CHENG KK
    Our choice is not binary between lockdown and herd immunity.
    BMJ. 2020;371:m4051.

  18. Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial).
    BMJ. 2020;371:m4232.

  19. LENZER J
    Covid-19: Experts debate merits of lockdowns versus "focused protection".
    BMJ. 2020;371:m4263.

  20. BOLLYKY TJ, Kickbusch I
    Preparing democracies for pandemics.
    BMJ. 2020;371:m4088.

    Covid-19: GPs are told to be ready to deliver vaccine from next month.
    BMJ. 2020;371:m4291.

  22. GODLEE F, Looi MK
    The BMJ interview: Chris Whitty, England's chief medical officer, on covid-19.
    BMJ. 2020;371:m4235.

  23. SECO VASCO JR, Curado Castano R, Mateus Gomez AM
    Uncertain evolution of untreated coronary syndromes during covid-19 pandemic.
    BMJ. 2020;371:m4250.

  24. KARATH K
    Covid-19: Hungary's pandemic response may have been worse than the virus.
    BMJ. 2020;371:m4153.

    Covid-19: Study findings strongly support use of pooled testing, say researchers.
    BMJ. 2020;371:m4267.

    Covid-19: Mass population testing is rolled out in Liverpool.
    BMJ. 2020;371:m4268.

    Br J Anaesth

  27. LONGOBARDO A, Montanari C, Shulman R, Benhalim S, et al
    Inhaled nitric oxide minimally improves oxygenation in COVID-19 related acute respiratory distress syndrome.
    Br J Anaesth. 2020 Oct 14. pii: S0007-0912(20)30843.

  28. FFRENCH-O'CARROLL R, Feeley T, Tan MH, Magner C, et al
    Psychological impact of COVID-19 on staff working in paediatric and adult critical care.
    Br J Anaesth. 2020 Oct 10. pii: S0007-0912(20)30824.

  29. HARRIS S, Palmer E, Fong K
    Trials in pandemics: here we go again?
    Br J Anaesth. 2020 Oct 10. pii: S0007-0912(20)30840.

    Clin Chem

  30. LOPEZ J
    Tribute to All Covid-19 Fighters in Healthcare.
    Clin Chem. 2020;66:1472-1473.

    Clin Infect Dis

  31. SIMS MD, Maine GN, Childers KL, Podolsky RH, et al
    COVID-19 seropositivity and asymptomatic rates in healthcare workers are associated with job function and masking.
    Clin Infect Dis. 2020 Nov 5. pii: 5956266. doi: 10.1093/cid/ciaa1684.
    PubMed         Abstract available

  32. LEI JH, Xu Y, Jiang YF, Shi ZH, et al
    Clustering cases of Chlamydia psittaci pneumonia in COVID-19 screening ward staff.
    Clin Infect Dis. 2020 Nov 5. pii: 5956268. doi: 10.1093/cid/ciaa1681.
    PubMed         Abstract available

  33. PETERSEN LR, Sami S, Vuong N, Pathela P, et al
    Lack of antibodies to SARS-CoV-2 in a large cohort of previously infected persons.
    Clin Infect Dis. 2020 Nov 4. pii: 5956137. doi: 10.1093/cid/ciaa1685.
    PubMed         Abstract available

  34. ARVISAIS-ANHALT S, Lehmann CU, Park JY, Araj E, et al
    What the COVID-19 Pandemic Has Reinforced: The Need for Accurate Data.
    Clin Infect Dis. 2020 Nov 4. pii: 5956084. doi: 10.1093/cid/ciaa1686.
    PubMed         Abstract available

  35. HURST JH, Heston SM, Chambers HN, Cunningham HM, et al
    SARS-CoV-2 Infections Among Children in the Biospecimens from Respiratory Virus-Exposed Kids (BRAVE Kids) Study.
    Clin Infect Dis. 2020 Nov 3. pii: 5952826. doi: 10.1093/cid/ciaa1693.
    PubMed         Abstract available

  36. VIJAYAN T, Shin M, Adamson PC, Harris C, et al
    Beyond the 405 and the 5: Geographic variations and factors associated with SARS-CoV-2 positivity rates in Los Angeles County.
    Clin Infect Dis. 2020 Nov 3. pii: 5952808. doi: 10.1093/cid/ciaa1692.
    PubMed         Abstract available

  37. HUH K, Jung J, Hong J, Kim M, et al
    Impact of non-pharmaceutical interventions on the incidence of respiratory infections during the COVID-19 outbreak in Korea: a nationwide surveillance study.
    Clin Infect Dis. 2020 Nov 5. pii: 5956267. doi: 10.1093/cid/ciaa1682.
    PubMed         Abstract available

    Infect Control Hosp Epidemiol

  38. DELMAS C, Plu-Bureau G, Canoui E, Mouthon L, et al
    Clinical characteristics and persistence of SARS-CoV-2 IgG antibodies in 4607 French healthcare workers: comparison with European countries.
    Infect Control Hosp Epidemiol. 2020 Nov 4:1-9. doi: 10.1017/ice.2020.1309.

  39. BAGGIANI A, Briani S, Luchini G, Giraldi M, et al
    Analysis of costs for the pandemic management in a tertiary hospital in Italy: an investment for a more resilient structure.
    Infect Control Hosp Epidemiol. 2020 Nov 4:1-6. doi: 10.1017/ice.2020.1311.

  40. TSANG KK, Mertz D, O'Neill C, Khan S, et al
    Silver linings of the COVID-19 pandemic from an infection prevention and control perspective.
    Infect Control Hosp Epidemiol. 2020 Nov 4:1-7. doi: 10.1017/ice.2020.1310.
    PubMed         Abstract available

    Int J Infect Dis

  41. ESPINDOLA OM, Brandao CO, Gomes YCP, Siqueira M, et al
    Cerebrospinal fluid findings in neurological diseases associated with COVID-19 and insights into mechanisms of disease development.
    Int J Infect Dis. 2020 Oct 27. pii: S1201-9712(20)32247.
    PubMed         Abstract available

  42. HIRAYAMA A, Masui J, Murayama A, Fujita S, et al
    The characteristics and clinical course of patients with COVID-19 who received invasive mechanical ventilation in Osaka, Japan.
    Int J Infect Dis. 2020 Oct 27. pii: S1201-9712(20)32255.
    PubMed         Abstract available

  43. YASSINE HM, Al-Jighefee H, Al-Sadeq DW, Dargham SR, et al
    Performance evaluation of five ELISA kits for detecting anti-SARS-COV-2 IgG antibodies.
    Int J Infect Dis. 2020 Oct 27. pii: S1201-9712(20)32246.
    PubMed         Abstract available

  44. CABELLO A, Zamarro B, Nistal S, Victor V, et al
    Int J Infect Dis. 2020 Oct 27. pii: S1201-9712(20)32264.
    PubMed         Abstract available

  45. CHOI MJ, Kang M, Shin SY, Noh JY, et al
    Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study.
    Int J Infect Dis. 2020 Oct 27. pii: S1201-9712(20)32266.
    PubMed         Abstract available

  46. IPPOLITO G, Lauria FN, Locatelli F, Magrini N, et al
    Lessons from the COVID-19 Pandemic - Unique Opportunities for Unifying, Revamping and Reshaping Epidemic Preparedness of Europe's Public Health Systems.
    Int J Infect Dis. 2020 Nov 2. pii: S1201-9712(20)32303.

  47. LOEVINSOHN G, Hardick J, Sinywimaanzi P, Fenstermacher KZJ, et al
    Respiratory pathogen diversity and co-infections in rural Zambia.
    Int J Infect Dis. 2020 Oct 27. pii: S1201-9712(20)32258.
    PubMed         Abstract available

    Intensive Care Med

  48. JONIGK D, Markl B, Helms J
    COVID-19: what the clinician should know about post-mortem findings.
    Intensive Care Med. 2020 Nov 3. pii: 10.1007/s00134-020-06302.

    J Infect

  49. HAMED E
    Rates of recurrent positive SARS-CoV-2 swab results among patients attending primary care in Qatar.
    J Infect. 2020 Oct 31. pii: S0163-4453(20)30691.

  50. SCHIRINZI A, Pesce F, Laterza R, D'Alise MG, et al
    Pentraxin 3: potential prognostic role in SARS-CoV-2 patients admitted to the emergency department.
    J Infect. 2020 Nov 1. pii: S0163-4453(20)30687.

  51. WANG X, Lin L, Xuan Z, Xu J, et al
    Risk communication on behavioral responses during COVID-19 among general population in China: a rapid national study.
    J Infect. 2020 Oct 31. pii: S0163-4453(20)30689.
    PubMed         Abstract available

  52. SAITO S, Asai Y, Matsunaga N, Hayakawa K, et al
    First and second COVID-19 waves in Japan: A comparison of disease severity and characteristics: Comparison of the two COVID-19 waves in Japan.
    J Infect. 2020 Nov 2. pii: S0163-4453(20)30693.

  53. GANDINI O, Criniti A, Gagliardi MC, Ballesio L, et al
    Sex-disaggregated data confirm serum ferritin as an independent predictor of disease severity both in male and female COVID-19 patients.
    J Infect. 2020 Oct 22. pii: S0163-4453(20)30654.

  54. DAHDOUH E, Lazaro-Perona F, Romero-Gomez MP, Mingorance J, et al
    Ct values from SARS-CoV-2 diagnostic PCR assays should not be used as direct estimates of viral load.
    J Infect. 2020 Oct 24. pii: S0163-4453(20)30675.

  55. ARAN D, Beachler DC, Lanes S, Overhage JM, et al
    Prior Presumed Coronavirus Infection Reduces COVID-19 Risk: A Cohort Study.
    J Infect. 2020 Oct 27. pii: S0163-4453(20)30683.
    PubMed         Abstract available

  56. MERLI M, Pasulo L, Perricone G, Travi G, et al
    Impact of immunosuppressive therapy on the severity of COVID-19 in solid organ transplant recipients.
    J Infect. 2020 Oct 27. pii: S0163-4453(20)30685.

    J Med Virol

  57. HOANG T
    Systematic review and meta-analysis of factors associated with re-positive viral RNA after recovery from COVID-19.
    J Med Virol. 2020 Nov 2. doi: 10.1002/jmv.26648.
    PubMed         Abstract available

  58. LIU C, Yu X, Gao C, Zhang L, et al
    Characterization of Antibody Responses to SARS-CoV-2 in Convalescent COVID-19 Patients.
    J Med Virol. 2020 Nov 2. doi: 10.1002/jmv.26646.
    PubMed         Abstract available

  59. PENROD Y, Garcia D, Dunn ST
    Evaluation of transport media for laboratory detection of SARS-CoV-2 in upper respiratory tract swab specimens.
    J Med Virol. 2020 Oct 31. doi: 10.1002/jmv.26643.
    PubMed         Abstract available

  60. HAN X, Ye Q
    Kidney involvement in COVID-19 and its treatments.
    J Med Virol. 2020 Nov 5. doi: 10.1002/jmv.26653.
    PubMed         Abstract available

  61. MASCOLO S, Carleo MA, Contieri M, Izzo S, et al
    SARS-CoV-2 and inflammatory responses: from mechanisms to the potential therapeutic use of intravenous immunoglobulin.
    J Med Virol. 2020 Nov 5. doi: 10.1002/jmv.26651.
    PubMed         Abstract available

  62. LIN SF, Lai CC, Chao CM, Tang HJ, et al
    Impact of COVID-19 preventative measures on dengue infections in Taiwan.
    J Med Virol. 2020 Nov 3. doi: 10.1002/jmv.26650.
    PubMed         Abstract available

  63. ALBERT E, Bracho MA, Serrano A, Ferrer B, et al
    Assessing the potential association between SARS-CoV-2 RNA load in the respiratory tract and COVID-19 mortality.
    J Med Virol. 2020 Nov 2. doi: 10.1002/jmv.26644.
    PubMed         Abstract available

  64. OZCELIK N, Ozyurt S, Yilmaz Kara B, Gumus A, et al
    The Value of Platelet Count and Platelet Indices in Differentiation of COVID-19 and Influenza Pneumonia.
    J Med Virol. 2020 Nov 2. doi: 10.1002/jmv.26645.
    PubMed         Abstract available

  65. ALSHARIF KF, Alzahrani AB, Alharbi AO, Algregri TO, et al
    The prevalence of MERS-CoV among military personnel and their families: A single center study.
    J Med Virol. 2020 Oct 31. doi: 10.1002/jmv.26642.
    PubMed         Abstract available

    J Thorac Oncol

  66. BAKHRIBAH H, Alfayea T
    Immunotherapy and Coronavirus Disease 2019: Challenges and Possibilities.
    J Thorac Oncol. 2020;15:1709-1710.

    J Travel Med

  67. STEFFEN R, Lautenschlager S, Fehr J
    Travel restrictions and lockdown during the COVID-19 pandemic-impact on notified infectious diseases in Switzerland.
    J Travel Med. 2020 Sep 29. pii: 5912954. doi: 10.1093.

  68. BUSS I, Genton B, D'Acremont V
    Etiology of fever in returning travelers and migrants: a systematic review and meta-analysis.
    J Travel Med. 2020 Nov 4. pii: 5955503. doi: 10.1093.
    PubMed         Abstract available

  69. ALSHAHRANI NZ, Alshahrani SM, Alshahrani AM, Leggat PA, et al
    Compliance of the Gulf Cooperation Council airlines with COVID-19 mitigation measures.
    J Travel Med. 2020 Nov 4. pii: 5955502. doi: 10.1093.

  70. SHANKS GD, Brundage JF
    Did coronaviruses cause 'influenza epidemics' prior to 1918?
    J Travel Med. 2020 Nov 4. pii: 5955501. doi: 10.1093.
    PubMed         Abstract available

    J Virol

  71. GUTIERREZ-ALVAREZ J, Wang L, Fernandez-Delgado R, Li K, et al
    Middle East Respiratory Syndrome Coronavirus Gene 5 Modulates Pathogenesis in Mice.
    J Virol. 2020 Nov 3. pii: JVI.01172-20. doi: 10.1128/JVI.01172.
    PubMed         Abstract available

  72. DIEZ-FUERTES F, Iglesias-Caballero M, Garcia Perez J, Monzon S, et al
    J Virol. 2020 Oct 30. pii: JVI.01583-20. doi: 10.1128/JVI.01583.
    PubMed         Abstract available

  73. HEISE M, Dermody TS, Casadevall A, Sandri-Goldin RM, et al
    The Decision to Publish Gutierrez-Alvarez et al., "Middle East Respiratory Syndrome Coronavirus Gene 5 Modulates Pathogenesis in Mice".
    J Virol. 2020 Nov 3. pii: JVI.02118-20. doi: 10.1128/JVI.02118.
    PubMed         Abstract available

  74. FENWICK C, Croxatto A, Coste AT, Pojer F, et al
    Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies.
    J Virol. 2020 Nov 3. pii: JVI.01828-20. doi: 10.1128/JVI.01828.
    PubMed         Abstract available


    Newly Discovered Cellular Pathway Blocks Ebola, COVID-19 Viruses.
    JAMA. 2020;324:1712.

  76. PLOTT CF, Kachalia AB, Sharfstein JM
    Unexpected Health Insurance Profits and the COVID-19 Crisis.
    JAMA. 2020;324:1713-1714.

    Seasonal Influenza Vaccination.
    JAMA. 2020 Aug 14. pii: 2769679. doi: 10.1001/jama.2020.14772.


  78. HOLT E
    Slovakia to test all adults for SARS-CoV-2.
    Lancet. 2020;396:1386-1387.

  79. HORTON R
    Offline: COVID-19-a crisis of power.
    Lancet. 2020;396:1383.

  80. FENNELLY K, Whalen CC
    Asymptomatic health-care worker screening during the COVID-19 pandemic.
    Lancet. 2020;396:1393.

  81. CHOW A, Htun HL, Kyaw WM, Lee LT, et al
    Asymptomatic health-care worker screening during the COVID-19 pandemic.
    Lancet. 2020;396:1393-1394.

  82. TREIBEL TA, Manisty C, Andiapen M, Pade C, et al
    Asymptomatic health-care worker screening during the COVID-19 pandemic - Authors' reply.
    Lancet. 2020;396:1394-1395.

  83. REDDY S, Dumbill R, Akhtar MZ, Udupa V, et al
    Transplant programmes in areas with high SARS-CoV-2 transmission.
    Lancet. 2020;396:1395-1396.

  84. QU Z, Oedingen C, Bartling T, Schrem H, et al
    Organ procurement and transplantation in Germany during the COVID-19 pandemic.
    Lancet. 2020;396:1395.

  85. GORTAZAR C, Del-Rio FJR, Dominguez L, de la Fuente J, et al
    Host or pathogen-related factors in COVID-19 severity?
    Lancet. 2020;396:1396-1397.

  86. OKELL LC, Verity R, Katzourakis A, Volz EM, et al
    Host or pathogen-related factors in COVID-19 severity? - Authors' reply.
    Lancet. 2020;396:1397.

  87. BALL P
    David Hare's fiery account of COVID-19.
    Lancet. 2020;396:878-879.

    Lancet Diabetes Endocrinol

  88. GUBBI S, Nazari MA, Taieb D, Klubo-Gwiezdzinska J, et al
    Catecholamine physiology and its implications in patients with COVID-19.
    Lancet Diabetes Endocrinol. 2020 Oct 28. pii: S2213-8587(20)30342.
    PubMed         Abstract available

    Food for thought during school closures.
    Lancet Diabetes Endocrinol. 2020;8:869.

    Lancet Gastroenterol Hepatol

  90. TAVABIE OD, Abeysekera KWM, Tranah TH, Nayagam JS, et al
    COVID-19 and liver transplantation: the jury is still out.
    Lancet Gastroenterol Hepatol. 2020 Oct 30. pii: S2468-1253(20)30313.

  91. WEBB GJ, Marjot T, Barnes E, Barritt AS 4th, et al
    COVID-19 and liver transplantation: the jury is still out - Authors' reply.
    Lancet Gastroenterol Hepatol. 2020 Oct 30. pii: S2468-1253(20)30337.

    Lancet Infect Dis

  92. NG OT, Marimuthu K, Koh V, Pang J, et al
    SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study.
    Lancet Infect Dis. 2020 Nov 2. pii: S1473-3099(20)30833.
    PubMed         Abstract available

  93. IVERSEN K, Bundgaard H, Harritshoj L, Ullum H, et al
    Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies - Authors' reply.
    Lancet Infect Dis. 2020 Oct 30. pii: S1473-3099(20)30849.

  94. VAN ELSLANDE J, Andre E, Van Ranst M, Lagrou K, et al
    Immunoassays for anti-SARS-CoV-2 antibodies: recent insights.
    Lancet Infect Dis. 2020 Oct 30. pii: S1473-3099(20)30846.

  95. CHOY KW
    Specificity and cross-reactivity of a test for anti-SARS-CoV-2 antibodies.
    Lancet Infect Dis. 2020 Oct 30. pii: S1473-3099(20)30787.

  96. BADR HS, Gardner LM
    Limitations of using mobile phone data to model COVID-19 transmission in the USA.
    Lancet Infect Dis. 2020 Nov 2. pii: S1473-3099(20)30861.

    Lancet Neurol

    Neglect during a crisis: the stark reality.
    Lancet Neurol. 2020;19:879.

    Lancet Respir Med

  98. KIRBY T
    COVID-19 human challenge studies in the UK.
    Lancet Respir Med. 2020 Oct 30. pii: S2213-2600(20)30518.

  99. ZAEH SE, Page KR, Berger ZD, Daly L, et al
    Juntos en la pandemia de COVID-19 (together in the COVID-19 pandemic): health-care professionals and the Latinx community.
    Lancet Respir Med. 2020 Oct 30. pii: S2213-2600(20)30519.

  100. ZOUFALY A, Poglitsch M, Aberle JH, Hoepler W, et al
    Human recombinant soluble ACE2 in severe COVID-19.
    Lancet Respir Med. 2020;8:1154-1158.

    Life Sci

  101. PAN ZY, Chang YX, Han N, Hou FY, et al
    Short-term high-dose gavage of hydroxychloroquine changes gut microbiota but not the intestinal integrity and immunological responses in mice.
    Life Sci. 2020 Oct 22:118450. doi: 10.1016/j.lfs.2020.118450.
    PubMed         Abstract available

    MMWR Morb Mortal Wkly Rep

  102. JENKINS R, Burke RM, Hamilton J, Fazekas K, et al
    Notes from the Field: Development of an Enhanced Community-Focused COVID-19 Surveillance Program - Hopi Tribe, JuneJuly 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1660-1661.

  103. KIRBIYIK U, Binder AM, Ghinai I, Zawitz C, et al
    Network Characteristics and Visualization of COVID-19 Outbreak in a Large Detention Facility in the United States - Cook County, Illinois, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1625-1630.
    PubMed         Abstract available

  104. WOODWORTH KR, Olsen EO, Neelam V, Lewis EL, et al
    Birth and Infant Outcomes Following Laboratory-Confirmed SARS-CoV-2 Infection in Pregnancy - SET-NET, 16 Jurisdictions, March 29-October 14, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1635-1640.
    PubMed         Abstract available

  105. GRIJALVA CG, Rolfes MA, Zhu Y, McLean HQ, et al
    Transmission of SARS-COV-2 Infections in Households - Tennessee and Wisconsin, April-September 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1631-1634.
    PubMed         Abstract available

  106. FISHER KA, Olson SM, Tenforde MW, Feldstein LR, et al
    Telework Before Illness Onset Among Symptomatic Adults Aged >/=18 Years With and Without COVID-19 in 11 Outpatient Health Care Facilities - United States, July 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1648-1653.
    PubMed         Abstract available

  107. HIRSCHMAN J, Kaur H, Honanie K, Jenkins R, et al
    A SARS-CoV-2 Outbreak Illustrating the Challenges in Limiting the Spread of the Virus - Hopi Tribe, May-June 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1654-1659.
    PubMed         Abstract available

  108. ZAMBRANO LD, Ellington S, Strid P, Galang RR, et al
    Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status - United States, January 22-October 3, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1641-1647.
    PubMed         Abstract available

    N Engl J Med

    Policy Lessons from Our Covid Experience.
    N Engl J Med. 2020;383:e96.

    Tribal Truce - How Can We Bridge the Partisan Divide and Conquer Covid?
    N Engl J Med. 2020;383:1682-1685.

  111. COWIE BC, MacLachlan JH
    Early Spread of SARS-CoV-2 in the Icelandic Population.
    N Engl J Med. 2020;383.

  112. GUDBJARTSSON DF, Stefansson K
    Early Spread of SARS-CoV-2 in the Icelandic Population. Reply.
    N Engl J Med. 2020;383.

  113. AGARWAL SD, Sommers BD
    Insurance Coverage after Job Loss - The Importance of the ACA during the Covid-Associated Recession.
    N Engl J Med. 2020;383:1603-1606.


    Scientists aghast as hopes for landslide Biden election victory vanish.
    Nature. 2020 Nov 4. pii: 10.1038/d41586-020-03120.

  115. STADLBAUER D, Tan J, Jiang K, Hernandez MM, et al
    Repeated cross-sectional sero-monitoring of SARS-CoV-2 in New York City.
    Nature. 2020 Nov 3. pii: 10.1038/s41586-020-2912.
    PubMed         Abstract available

  116. MEFFRE E, Iwasaki A
    Interferon deficiency can lead to severe COVID.
    Nature. 2020 Nov 2. pii: 10.1038/d41586-020-03070.

  117. LEWIS D
    Why schools probably aren't COVID hotspots.
    Nature. 2020;587:17.

  118. O'DRISCOLL M, Dos Santos GR, Wang L, Cummings DAT, et al
    Age-specific mortality and immunity patterns of SARS-CoV-2.
    Nature. 2020 Nov 2. pii: 10.1038/s41586-020-2918.
    PubMed         Abstract available

    Four ways Trump has meddled in pandemic science - and why it matters.
    Nature. 2020 Nov 3. pii: 10.1038/d41586-020-03035.


    The quiet spring of 2020.
    Science. 2020;370:523-524.

    Travel Med Infect Dis

  121. TIRUPATHI R, Muradova V, Shekhar R, Salim SA, et al
    COVID-19 disparity among racial and ethnic minorities in the US: A cross sectional analysis.
    Travel Med Infect Dis. 2020;38:101904.
    PubMed         Abstract available

  122. DREYER NA, Reynolds M, DeFilippo Mack C, Brinkley E, et al
    Self-reported symptoms from exposure to Covid-19 provide support to clinical diagnosis, triage and prognosis: An exploratory analysis.
    Travel Med Infect Dis. 2020 Nov 2:101909. doi: 10.1016/j.tmaid.2020.101909.
    PubMed         Abstract available

  123. SZENTE FONSECA SN, Queiroz de Sousa A, Wolkoff AG, Moreira MS, et al
    Risk of Hospitalization for Covid-19 Outpatients Treated with Various Drug Regimens in Brazil: Comparative Analysis.
    Travel Med Infect Dis. 2020 Oct 30:101906. doi: 10.1016/j.tmaid.2020.101906.
    PubMed         Abstract available

    Zhonghua Jie He He Hu Xi Za Zhi

  124. NIE NF, He Y
    [Potential therapeutic drugs for novel coronavirus pneumonia].
    Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:970-974.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.